Aligned Genetics, Inc. (KOSDAQ:238120)
South Korea · Delayed Price · Currency is KRW 2,570.00
+90.00 (3.63%)
At close: Oct 30, 2026
Aligned Genetics Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 16,162 | 16,016 | 15,778 | 15,215 | 13,753 | 11,762 |
Revenue Growth | -5.88% | 1.51% | 3.70% | 10.63% | 16.92% | 47.82% |
Gross Profit Gross Profit Growth | 11,874 | 11,221 | 11,148 | 10,659 | 8,755 | 7,338 |
Operating Income Operating Income Growth | 2,526 | 2,443 | 2,780 | 3,337 | 2,849 | 2,179 |
Net Income Net Income Growth | 4,642 | 2,911 | 4,128 | 3,236 | 2,333 | 5,542 |
Earnings Per Share EPS Growth | 329.61 | 206.00 | 287.00 | 225.00 | 162.00 | 385.40 |
EPS Growth | 41.95% | -28.22% | 27.56% | 38.89% | -57.97% | 756.45% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
South Korea South Korea Growth | 6,753 | 7,621 | 7,352 | 1,868 | 2,324 | 2,643 |
United States of America (USA) United States of America (USA) Growth | 5,279 | 5,248 | 5,847 | 4,820 | 3,755 | 3,077 |
France France Growth | 3,701 | 3,048 | 2,578 | 1,869 | 1,086 | 676.17 |
Japan Japan Growth | - | 99.02 | - | 944.57 | 755.66 | 979.71 |
Total Total Growth | 16,162 | 16,016 | 15,778 | 15,215 | 13,753 | 11,762 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 15,438 | 14,618 | 17,639 | 14,927 | 13,696 | 13,137 |
Total Debt Total Debt Growth | 14,968 | 14,505 | 2,964 | 4,663 | 4,379 | 4,436 |
Net Cash (Debt) Net Cash Growth | 469.97 | 113.01 | 14,676 | 10,264 | 9,317 | 8,701 |
Net Cash Growth | -96.68% | -99.23% | 42.98% | 10.17% | 7.07% | -20.97% |
Net Cash Per Share Net Cash Per Share Growth | 33.43 | 8.01 | 1020.63 | 713.81 | 647.93 | 605.15 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 3,030 | 3,605 | 3,065 | 2,849 | 2,222 | 135.97 |
Capital Expenditures CapEx Growth | -10,929 | -11,065 | -257.69 | -878.54 | -2,001 | -3,307 |
Free Cash Flow Free Cash Flow Growth | -7,899 | -7,459 | 2,808 | 1,970 | 220.98 | -3,171 |
Free Cash Flow Growth | - | - | 42.52% | 791.50% | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 73.47% | 70.06% | 70.66% | 70.06% | 63.66% | 62.38% |
Operating Margin | 15.63% | 15.25% | 17.62% | 21.93% | 20.72% | 18.52% |
Pretax Margin | 23.82% | 16.54% | 28.79% | 22.51% | 17.76% | 32.41% |
Profit Margin | 28.72% | 18.18% | 26.16% | 21.27% | 16.96% | 47.12% |
FCF Margin | -48.87% | -46.58% | 17.79% | 12.95% | 1.61% | -26.96% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 7.80 | 18.69 | 10.54 | 17.91 | 23.21 | 11.12 |
P/FCF Ratio | - | - | 15.49 | 29.41 | 244.98 | - |
PS Ratio | 2.26 | 3.40 | 2.76 | 3.81 | 3.94 | 5.24 |